These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11113226)

  • 1. Mechanisms of immunomodulation by glatiramer acetate.
    Gran B; Tranquill LR; Chen M; Bielekova B; Zhou W; Dhib-Jalbut S; Martin R
    Neurology; 2000 Dec; 55(11):1704-14. PubMed ID: 11113226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.
    Dhib-Jalbut S; Chen M; Said A; Zhan M; Johnson KP; Martin R
    J Neuroimmunol; 2003 Jul; 140(1-2):163-71. PubMed ID: 12864985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.
    Aharoni R; Teitelbaum D; Arnon R; Sela M
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):634-9. PubMed ID: 9892685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cells.
    Chou YK; Weinberg AD; Buenafe A; Bourdette DN; Whitham R; Kaleeba JA; Robey IF; Kavanagh DG; Offner H; Vandenbark AA
    J Neurosci Res; 1996 Sep; 45(6):838-51. PubMed ID: 8892096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS.
    Chen M; Gran B; Costello K; Johnson K; Martin R; Dhib-Jalbut S
    Mult Scler; 2001 Aug; 7(4):209-19. PubMed ID: 11548979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
    Rohowsky-Kochan C; Molinaro D; Cook SD
    Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis.
    Putheti P; Soderstrom M; Link H; Huang YM
    J Neuroimmunol; 2003 Nov; 144(1-2):125-31. PubMed ID: 14597106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients.
    Qin Y; Zhang DQ; Prat A; Pouly S; Antel J
    J Neuroimmunol; 2000 Aug; 108(1-2):201-6. PubMed ID: 10900354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis.
    Schmied M; Duda PW; Krieger JI; Trollmo C; Hafler DA
    Clin Immunol; 2003 Mar; 106(3):163-74. PubMed ID: 12706402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and murine CD4 T cell reactivity to a complex antigen: recognition of the synthetic random polypeptide glatiramer acetate.
    Duda PW; Krieger JI; Schmied MC; Balentine C; Hafler DA
    J Immunol; 2000 Dec; 165(12):7300-7. PubMed ID: 11120865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glatiramer acetate: mechanisms of action in multiple sclerosis.
    Schrempf W; Ziemssen T
    Autoimmun Rev; 2007 Aug; 6(7):469-75. PubMed ID: 17643935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
    Karandikar NJ; Crawford MP; Yan X; Ratts RB; Brenchley JM; Ambrozak DR; Lovett-Racke AE; Frohman EM; Stastny P; Douek DC; Koup RA; Racke MK
    J Clin Invest; 2002 Mar; 109(5):641-9. PubMed ID: 11877472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cells.
    Ragheb S; Abramczyk S; Lisak D; Lisak R
    Mult Scler; 2001 Feb; 7(1):43-7. PubMed ID: 11321193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy.
    Teitelbaum D; Brenner T; Abramsky O; Aharoni R; Sela M; Arnon R
    Mult Scler; 2003 Dec; 9(6):592-9. PubMed ID: 14664472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells.
    Wiesemann E; Klatt J; Sönmez D; Blasczyk R; Heidenreich F; Windhagen A
    J Neuroimmunol; 2001 Sep; 119(1):137-44. PubMed ID: 11525811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.
    Ziemssen T; Kümpfel T; Klinkert WE; Neuhaus O; Hohlfeld R
    Brain; 2002 Nov; 125(Pt 11):2381-91. PubMed ID: 12390966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis.
    Dhib-Jalbut S; Chen M; Henschel K; Ford D; Costello K; Panitch H
    Mult Scler; 2002 Dec; 8(6):485-91. PubMed ID: 12474988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
    Tennakoon DK; Mehta RS; Ortega SB; Bhoj V; Racke MK; Karandikar NJ
    J Immunol; 2006 Jun; 176(11):7119-29. PubMed ID: 16709875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.
    Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
    Int Immunol; 2003 Sep; 15(9):1073-80. PubMed ID: 12917259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.